STING, a promising target for small molecular immune modulator: A review

Eur J Med Chem. 2021 Feb 5:211:113113. doi: 10.1016/j.ejmech.2020.113113. Epub 2020 Dec 18.

Abstract

Stimulator of interferon genes (STING) plays a crucial role in human innate immune system, which is gradually concerned following the emerging immunotherapy. Activated STING induces the production of type I interferons (IFNs) and proinflammatory cytokines through STING-TBK1-IRF3/NF-κB pathway, which could be applied into the treatment of infection, inflammation, and tumorigenesis. Here, we provided a detailed summary of STING from its structure, function and regulation. Especially, we illustrated the canonical or noncanonical cyclic dinucleotides (CDNs) and synthetic small molecules for STING activation or inhibition and their efficacy in related diseases. Importantly, we particularly emphasized the discovery, development and modification of STING agonist or antagonist, attempting to enlighten reader's mind for enriching small molecular modulator of STING. In addition, we summarized biological evaluation methods for the assessment of small molecules activity.

Keywords: Agonists; Antagonists; Cancer; Infection; Inflammation; Regulation; TING.

Publication types

  • Review

MeSH terms

  • Humans
  • Immunity, Innate / drug effects*
  • Membrane Proteins / pharmacology
  • Membrane Proteins / therapeutic use*
  • Models, Molecular

Substances

  • Membrane Proteins
  • STING1 protein, human